Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,128 | 9,130 | 11,197 | 12,402 | 7,633 |
| Receivables | 3,907 | 3,706 | 26 | 46 | 28 |
| TOTAL | $10,896 | $13,744 | $11,574 | $12,809 | $7,799 |
| Non-Current Assets | |||||
| PPE Net | 282 | 257 | 274 | 264 | 228 |
| TOTAL | $282 | $257 | $274 | $264 | $228 |
| Total Assets | $11,177 | $14,001 | $11,847 | $13,073 | $8,027 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,533 | 2,842 | 2,220 | 2,462 | 2,530 |
| Other current liabilities | 734 | 1,192 | N/A | N/A | N/A |
| TOTAL | $3,267 | $4,034 | $2,220 | $2,462 | $2,530 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,158 | 3,577 | 0 | 0 | 0 |
| TOTAL | $4,158 | $3,577 | $N/A | $N/A | $N/A |
| Total Liabilities | $7,425 | $7,611 | $2,220 | $2,462 | $2,530 |
| Shareholders' Equity | |||||
| Common Shares | 215,389 | 209,597 | 216,151 | 200,867 | 198,202 |
| Retained earnings | -236,661 | -227,136 | -231,152 | -213,216 | -213,341 |
| Other shareholders' equity | 3,214 | 3,079 | 3,175 | 3,054 | 403 |
| TOTAL | $3,753 | $6,390 | $9,628 | $10,611 | $5,497 |
| Total Liabilities And Equity | $11,177 | $14,001 | $11,847 | $13,073 | $8,027 |